Showing results (1481-1490 of 1,887) with videos related to
Sort By:
Pageof 189
Clinical and Experimental Dermatology|May 24, 2025
Outcomes of Psoriasis Area and Severity Index (PASI) and PASI components in two phase III trials of deucravacitinib in patients with moderate to severe plaque psoriasisMark Lebwohl, Melinda J Gooderham, Richard B Warren, et al.Plos One|April 11, 2013
The knowledge of colorectal cancer symptoms and risk factors among 10,078 screening participants: are high risk individuals more knowledgeable?Martin C S Wong, Hoyee W Hirai, Arthur K C Luk, et al.The Biochemical Journal|May 22, 2007
A novel murine protein with no effect on iron homoeostasis is homologous with transferrin and is the putative inhibitor of carbonic anhydraseFudi Wang, Adam P Lothrop, Nicholas G James, et al.Gastroenterology|August 8, 2007
Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter studyDan Turner, Anthony R Otley, David Mack, et al.Immunotherapy|September 29, 2023
Tezepelumab for the treatment of severe asthma: a plain language summary of the PATHWAY and NAVIGATOR studiesJonathan Corren, Andrew Menzies-Gow, Johan Bimmel, et al.Gut|August 31, 2010
Faecal calprotectin, lactoferrin, M2-pyruvate kinase and S100A12 in severe ulcerative colitis: a prospective multicentre comparison of predicting outcomes and monitoring responseD Turner, S T Leach, D Mack, et al.JAMA Dermatology|December 6, 2023
Risk of Paradoxical Eczema in Patients Receiving Biologics for PsoriasisAli Al-Janabi, Oras A Alabas, Zenas Z N Yiu, et al.NEJM Evidence|February 6, 2024
Tezepelumab and Mucus Plugs in Patients with Moderate-to-Severe AsthmaLars H Nordenmark, Åsa Hellqvist, Claire Emson, et al.The Journal of Dermatological Treatment|October 5, 2010
Improving clinical trial design in psoriasis: Perspectives from the global dermatology communityPeter van de Kerkhof, Jonathan Barker, Christopher E M Griffiths, et al.Journal of Medical Genetics|August 28, 2010
STXBP2 mutations in children with familial haemophagocytic lymphohistiocytosis type 5Valentina Cetica, Alessandra Santoro, Kimberly C Gilmour, et al.Pageof 189